Xcout IntelOxford BioTherapeutics
Oxford BioTherapeutics is a clinical-stage oncology company focused on developing first-in-class cancer therapeutics with a proprietary pipeline. The company operates from locations in Oxford, United Kingdom, as well as San Jose, California, and Morristown, New Jersey, in the United States.
Subscribe to see Oxford BioTherapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Oxford BioTherapeutics at a glance
Oxford BioTherapeutics is a biotech company headquartered in United Kingdom, founded in 2004. Xcout tracks 14 named people at Oxford BioTherapeutics, including Christian Rohlff (Chief Executive Officer, Oxford). Xcout recorded 2 job postings from Oxford BioTherapeutics in the last 90 days.
Oxford BioTherapeutics leadership
- Christian RohlffChief Executive Officer, Oxford
- Harald HaeskeChief Medical Officer, Oxford
- Benjamin ThomasSVP Operations, Oxford
- Martin BarnesSVP Bioinformatics and Information Systems, Oxford
- Andrew DickinsonVP of Clinical Operations, Oxford
- Matthew MetzgerVice President, US Operations
8 more named people on record for Oxford BioTherapeutics, with roles, board committees and tenure — see the full roster →
Hiring at Oxford BioTherapeutics
Xcout recorded 2 job postings from Oxford BioTherapeutics in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Oxford BioTherapeutics's hiring signals →
Oxford BioTherapeutics competitors
A few of Oxford BioTherapeutics's closest competitors — see the full list of competitors and alternatives →
Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, United Kingdom, focused on early oncology research before being acquired by Amgen.
Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company headquartered in Morristown, New Jersey, focused on developing precision therapies for genetically defined cancers.
Grey Wolf Therapeutics is a biotechnology company headquartered in the UK focused on delivering a new class of treatments to improve the lives of people with cancers and autoimmune disorders.
Oncolytics Biotech Inc. is a clinical-stage biotechnology company developing pelareorep, an investigational intravenously administered therapeutic. The company focuses on unleashing the power of the immune system and operates as a public company with a small team based in San Diego, California.
Orbus Therapeutics, Inc. is a pharmaceutical company headquartered in Menlo Park, California, dedicated to developing treatments for rare forms of cancer, including clinical trials for brain tumors.
Revolution Medicines is a clinical-stage oncology company that develops novel targeted therapies to outsmart cancer. The company focuses on discovering and advancing therapeutic pipelines for patients with difficult-to-treat tumors.
Get Oxford BioTherapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Oxford BioTherapeutics in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access